Biologics Contract Manufacturing Market on a Tear $14.4 Billion in 2022, Poised to Double by 2033, Persistence Market Research New York, Jan. 17, 2024 (GLOBE NEWSWIRE) -- The dynamic and rapidly expanding field of biologics contract manufacturing, also referred to as the biopharmaceutical CMO market, is witnessing...

AGC Biologics and Evax Partner to Advance Promising Equine Allergy Vaccine Candidate Seattle, Sept. 07, 2022 (GLOBE NEWSWIRE) -- AGC Biologics, a leading global Biopharmaceutical Contract Development and Manufacturing Organization (CDMO), today announced a new partnership with Evax,...